Investing.com -- Shares of Novo Nordisk (NYSE:NVO ... Analyst Sachin Jain at BofA Securities questioned if this was an offensive or defensive move. An offensive move would advance other ...

On Wednesday, BMO Capital Markets reiterated its Market Perform rating on Novo Nordisk (NYSE: NVO) shares, maintaining a price target of $64.00.According to InvestingPro data, Novo Nordisk, with ...

Target missed first-quarter sales estimates and said it was setting up a new office to try to accelerate its turnaround.

Company sources said Toyota plans to increase PHEVs from 2.4% last year to roughly 20% of its U.S. sales volume by 2030.

Macy’s beat earnings estimates for the first quarter, but cut its 2025 profit outlook as tariffs complicate its turnaround ...

Salesforce delivered a beat-and-raise quarter even with President Trump’s imposition of tariffs on imported goods.

Novo Nordisk announced the decision on Friday. Days earlier, Novo Nordisk cut its sales and profit forecast for the first time since the launch of Wegovy four years ago, though Jorgensen had ...

Despite Lars Fruergaard Jørgensen's resignation as Novo Nordisk's CEO, its stock price has risen 10% over the past two weeks.

I've been a Novo Nordisk bull for quite some time now, and I wouldn't be as spooked by the situation. Here's why. Novo Nordisk got a two-year-plus head start in the white-hot obesity drugs market, ...

Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.